https://www.mychesco.com/a/news/health-medical/research/xylocor-therapeutics-reports-sustained-results-in-12-month-extension-of-phase-2-exact-clinical-trial-of-xc001-novel-gene-therapy-for-refractory-angina/
XyloCor Therapeutics Reports Sustained Results in 12-Month Extension of Phase 2 EXACT Clinical Trial of XC001 Novel Gene Therapy for Refractory Angina